wellness tirzepatide Explained: The Future of Weight Management The science behind Tirzepatide… and

This dual incretin approach produces some of the most impressive weight loss results ever documented in clinical trials

Molecule of the Month: GLP-1 Receptor Agonists Popular and effective drugs for the treatment of obesity and diabetes Improving on a lizard toxin Small molecule mimics Exploring the Structure Compare how peptide-based and small molecule drugs bind to the GLP-1 receptor While peptide-based GLP-1 receptor agonists all bind to the GLP-1 receptor in similar ways, the small molecule orforglipron is much smaller with far fewer interactions

The typical starting point is 0.25 mg to 0.5 mg per week

Many patients remain on tirzepatide therapy for several months to allow time for dose adjustments, treatment optimization, and sustainable weight loss progress

We offer physician-guided medical weight loss, telehealth consultations, insurance verification, and transparent self-pay options for eligible patients throughout Florida and more than 20 states